Interestingly, 2 out of 24 (8.3%) mucinous carcinomas of the breast annotated in the data were identified as having SF3B1 K700E mutations and lacked mutations in additional significantly mutated genes or known cancer genes (Figure 1C). This evidence concerns the gene SF3B1 and cancer.